Tag | Content |
---|
EnhancerAtlas ID | HS023-15184 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr2:182168570-182170310 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF5 | MA0599.1 | chr2:182168941-182168951 | GCCCCGCCCC | + | 6.02 | NFIL3 | MA0025.1 | chr2:182169132-182169143 | TTATGTAACAT | + | 6.32 | PHOX2A | MA0713.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | PROP1 | MA0715.1 | chr2:182168571-182168582 | TAATTAAATTA | + | 6.32 | PROP1 | MA0715.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | Phox2b | MA0681.1 | chr2:182168571-182168582 | TAATTAAATTA | - | 6.62 | SPI1 | MA0080.4 | chr2:182168778-182168792 | CAAATGAGGAAGTT | + | 6.2 |
|
| Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
SE_10328 | chr2:182168501-182175302 | CD19_Primary | SE_11276 | chr2:182168380-182180787 | CD20 | SE_12124 | chr2:182168576-182175378 | CD3 | SE_13148 | chr2:182168713-182172653 | CD34_Primary_RO01480 | SE_13870 | chr2:182168554-182175255 | CD34_Primary_RO01536 | SE_14299 | chr2:182168531-182175400 | CD34_Primary_RO01549 | SE_22764 | chr2:182168390-182179973 | CD8_primiary | SE_25641 | chr2:182168497-182175170 | DND41 | SE_31286 | chr2:182168416-182175187 | Fetal_Thymus | SE_39630 | chr2:182168232-182172575 | Jurkat | SE_43571 | chr2:182168254-182180421 | MM1S | SE_58761 | chr2:182168231-182179528 | Ly1 | SE_60876 | chr2:182168489-182178681 | DHL6 | SE_61469 | chr2:182165015-182180772 | Toledo | SE_62509 | chr2:182165210-182180093 | Tonsil | SE_66350 | chr2:182168232-182172575 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I181303 | chr2 | 182168600 | 182180186 |
|
Enhancer Sequence | CTAATTAAAT TAAGATTTCA GCAAAAATCA GAGATAATTT TTTGAATATC TTGGCGATAT 60 ATGTGGGGGG ATGTACTACT TTTATTTTTA AAACTCTGTG AAAGTACCTC CTGCTGACCA 120 GGCAGAATTC TAAATAATTT ACAAATATTA ATTCAGATAA TCATACTGAC AACTCTATTC 180 AGGGTCTACT AGTGGGATGC CCAGTTTGCA AATGAGGAAG TTAAGTAGCT TATATTCAAG 240 GTCAGACCAC AAAGTGGCAG AATAGGATTC AAAATGACGC CAGAGTCTAT GTTACTGTTT 300 GAAAAGAATA TTCAGCCATA TCTGAGCAGG TTTTATTTAT TAATTAGAGG TCAAAGCCAT 360 GGAAAAGATT AGCCCCGCCC CAAGTCTTGG TAGCTTAGTG GCAGGTCATC TAGGGCCCTG 420 GAGTCTCCCT TTCAGCTGTC CCTCTGTGTG ATATTTTGGA GCTGGGGTCA TGCCTTACCT 480 GCCTCCTCCT GGGGCCCTAT CTGCTGAATA CTATGACAGC GGGCAATAAA GGGAAGTTAG 540 CATCAAAAGG CAGCCCTTCT CTTTATGTAA CATAGAAATG ACCCTTTCTT TATTTTTGAC 600 TGACCACAGC TACCTTAGTA TTAGGTTAGC CTTGGTTACA GACTGGGTTT TGGTTTTGGT 660 GATAAGTATG ACTTTTGTAA TTCTTTGAAA CCTCTGCAAT GCCTCTCAAT TGCCCTATGA 720 ACAATGTAAA TTTGGGAGTA TAACTAAATG CAGATCTTCA CAGATTGGAG TTTGAACTTG 780 CCTCTTCAGC AAGGGACTGG GACGGCTCTT TATTACTACG GGATGTTTTT CTCATCTTCT 840 AGAGCTTAAG TAAAAAAAAT CTAGTTTCTC TTTGGGTAGT GAGGATGAAC TGTAGATACT 900 TCTTCACAAG CTCAAGGAAA ACACATTAGA CTTTCCTAGT CATAAATGAA GTCTCATTAT 960 GCTACAGGAG AAAACAGAGT TTTAAAAGTA ACTATACTAT CTAACTCTTT TTTAGTTTTA 1020 TCACTGAATC TTGAATAATA GAACATAAGC AGTTGTTCGG ATTTAAATTA TTCTTCCCTC 1080 TTGAATTACT GTTCAACACC CTAAGATCAC CATACGTATT ATTTCAGAAA ATGAAGAGCC 1140 TTAAAAATTG TCTCAGAAAT TTTATTTCCT TATATTATAA TTGAAATTTG GTAACTTCCC 1200 TCAAGATTAA TAGAAAAGTT GTTCTAAAAT CAACAAAACA TGTTCACTTA ATTTTTTTCC 1260 CCCACACTGT GGGTAGGAGC TAATATTTAC TGAGGGTCCA GCACATGCCA GGCATTTTAC 1320 TTTACTTAAG CCCATGCTCA GTATATGTGG TGAATATTGC TTCTTTTTAT TTTATTGGCA 1380 AAGAAATGAA ATCTCAGAGG CATTAGACAA ATTACCCAAG CCTACCCAGG CCCTAAGAGG 1440 AGTCCAAACT GGGGTTATTC TGGCCTAAAA ATAATGTGCT TTGCCCATCA CAATACCACA 1500 AACTTTTTAA AATCTTGATC ATTTCCACAT TTCAATTAAT CATCAGCATC AATGACGCAC 1560 TTTAAAAGAG GAGGAGTATT TTTTAAAGAG AGACCTATTT ACTCTTTTGG TCGGAGGCGT 1620 AGAAATTATG CTAAATACTA TGCATAACTT ACTTTGGCAA GTGCAATGGT TAAAACTAAG 1680 TACTAGTGTG CTTAAATACT TCCTTATTCA ACAATTATAA TGCAGATTAA AGCCCAAGTG 1740
|